AOD-9604
Fat LossPerformance / Research-onlyExperimental
Synthetic GH fragment promoting lipolysis; GRAS status but unapproved for therapy.
For research use only.
Key Facts
- CAS
- 221231-10-3
- Molecular Weight (MW)
- 1815.1 g/mol
- Half-life
- ~20-30 minutes
- Unit
- mcg
- Administration Route
- Subcutaneous
- Frequency
- 1-2x daily
- Last updated
- 12/18/2025
- Targets
- Beta-3 adrenergic receptors
Overview
Synthetic GH fragment promoting lipolysis; GRAS status but unapproved for therapy.
Protocol
- Dosage Range
- 250-500 mcg per day
- Frequency
- 1-2x daily
- Cycle
- 8-12 weeks on, 4 weeks off
- Administration Route
- Subcutaneous
- Reconstitution Guide
- 3 mL BAC water for 5 mg vial
Science
Mechanism of Action
Selective lipolysis stimulation without IGF-1/glucose impact.
Targets
Beta-3 adrenergic receptors
Studies
- — Journal/year not available
Benefits
Targeted fat lossLean mass preservationLipid profile improvementJoint/cartilage support
Potential Side Effects
- Injection site irritation
- Headache
- Fatigue